Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 389 entries
Sorted by: Best Match Show Resources per page
Optimizing Toxic Chemical Removal through Defect-Induced UiO-66-NH.

Chemistry (Weinheim an der Bergstrasse, Germany)

Peterson GW, Destefano MR, Garibay SJ, Ploskonka A, McEntee M, Hall M, Karwacki CJ, Hupp JT, Farha OK.
PMID: 28949042
Chemistry. 2017 Nov 13;23(63):15913-15916. doi: 10.1002/chem.201704525. Epub 2017 Oct 24.

For the first time, an increasing number of defects were introduced to the metal-organic framework UiO-66-NH

Cite
Peterson GW, Destefano MR, Garibay SJ, et al. Optimizing Toxic Chemical Removal through Defect-Induced UiO-66-NH. Chemistry. 2017;23(63):15913-15916doi: 10.1002/chem.201704525.
Peterson, G. W., Destefano, M. R., Garibay, S. J., Ploskonka, A., McEntee, M., Hall, M., Karwacki, C. J., Hupp, J. T., & Farha, O. K. (2017). Optimizing Toxic Chemical Removal through Defect-Induced UiO-66-NH. Chemistry (Weinheim an der Bergstrasse, Germany), 23(63), 15913-15916. https://doi.org/10.1002/chem.201704525
Peterson, Gregory W, et al. "Optimizing Toxic Chemical Removal through Defect-Induced UiO-66-NH." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 23,63 (2017): 15913-15916. doi: https://doi.org/10.1002/chem.201704525
Peterson GW, Destefano MR, Garibay SJ, Ploskonka A, McEntee M, Hall M, Karwacki CJ, Hupp JT, Farha OK. Optimizing Toxic Chemical Removal through Defect-Induced UiO-66-NH. Chemistry. 2017 Nov 13;23(63):15913-15916. doi: 10.1002/chem.201704525. Epub 2017 Oct 24. PMID: 28949042.
Copy Download .nbib Format: NLM
SALMO and S3M: A Saliva Model and a Single Saliva Salt Model for Equilibrium Studies.

Bioinorganic chemistry and applications

Crea F, De Stefano C, Milea D, Pettignano A, Sammartano S.
PMID: 25733975
Bioinorg Chem Appl. 2015;2015:267985. doi: 10.1155/2015/267985. Epub 2015 Feb 04.

A model of synthetic saliva (SALMO, SALiva MOdel) is proposed for its use as standard medium in in vitro equilibrium and speciation studies of real saliva. The concentrations come out from the literature analysis of the composition of both...

Cite
Crea F, De Stefano C, Milea D, et al. SALMO and S3M: A Saliva Model and a Single Saliva Salt Model for Equilibrium Studies. Bioinorg Chem Appl. 2015;2015:267985doi: 10.1155/2015/267985.
Crea, F., De Stefano, C., Milea, D., Pettignano, A., & Sammartano, S. (2015). SALMO and S3M: A Saliva Model and a Single Saliva Salt Model for Equilibrium Studies. Bioinorganic chemistry and applications, 2015267985. https://doi.org/10.1155/2015/267985
Crea, Francesco, et al. "SALMO and S3M: A Saliva Model and a Single Saliva Salt Model for Equilibrium Studies." Bioinorganic chemistry and applications vol. 2015 (2015): 267985. doi: https://doi.org/10.1155/2015/267985
Crea F, De Stefano C, Milea D, Pettignano A, Sammartano S. SALMO and S3M: A Saliva Model and a Single Saliva Salt Model for Equilibrium Studies. Bioinorg Chem Appl. 2015;2015:267985. doi: 10.1155/2015/267985. Epub 2015 Feb 04. PMID: 25733975; PMCID: PMC4334860.
Copy Download .nbib Format: NLM
Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial.

Open forum infectious diseases

Mulligan MJ, Bernstein DI, Frey S, Winokur P, Rouphael N, Dickey M, Edupuganti S, Spearman P, Anderson E, Graham I, Noah DL, Mangal B, Kim S, Hill H, Whitaker J, Emery W, Beck A, Stephens K, Hartwell B, Ogilvie M, Rimann N, Osinski E, Destefano E, Gajadhar T, Strudwick A, Pierce K, Lai L, Yue L, Wang D, Ying C, Cline A, Foltz T, Wagner N, Dull G, Pacatte T, Taggart B, Johnson V, Haller L, Looney C, Li S, May M, Myers B, May R, Parker L, Cochran N, Bowen D, Bell M, Scoggins J, Burns A, Stablein C, Wolff M, Jolles B, Leung B, Lambert L, Shorer S, Buchanan W, Murray S, Chang S, Gorman R.
PMID: 25734170
Open Forum Infect Dis. 2014 Nov 18;1(3):ofu102. doi: 10.1093/ofid/ofu102. eCollection 2014 Dec.

BACKGROUND: Avian influenza A/H5N1 has threatened human health for nearly 2 decades. Avian influenza A vaccine without adjuvant is poorly immunogenic. A flexible rapid tactic for mass vaccination will be needed if a pandemic occurs.METHODS: A multicenter, randomized, blinded...

Cite
Mulligan MJ, Bernstein DI, Frey S, et al. Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open Forum Infect Dis. 2014;1(3):ofu102doi: 10.1093/ofid/ofu102.
Mulligan, M. J., Bernstein, D. I., Frey, S., Winokur, P., Rouphael, N., Dickey, M., Edupuganti, S., Spearman, P., Anderson, E., Graham, I., Noah, D. L., Mangal, B., Kim, S., Hill, H., Whitaker, J., Emery, W., Beck, A., Stephens, K., Hartwell, B., Ogilvie, M., Rimann, N., Osinski, E., Destefano, E., Gajadhar, T., Strudwick, A., Pierce, K., Lai, L., Yue, L., Wang, D., Ying, C., Cline, A., Foltz, T., Wagner, N., Dull, G., Pacatte, T., Taggart, B., Johnson, V., Haller, L., Looney, C., Li, S., May, M., Myers, B., May, R., Parker, L., Cochran, N., Bowen, D., Bell, M., Scoggins, J., Burns, A., Stablein, C., Wolff, M., Jolles, B., Leung, B., Lambert, L., Shorer, S., Buchanan, W., Murray, S., Chang, S., & Gorman, R. (2014). Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open forum infectious diseases, 1(3), ofu102. https://doi.org/10.1093/ofid/ofu102
Mulligan, Mark J, et al. "Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial." Open forum infectious diseases vol. 1,3 (2014): ofu102. doi: https://doi.org/10.1093/ofid/ofu102
Mulligan MJ, Bernstein DI, Frey S, Winokur P, Rouphael N, Dickey M, Edupuganti S, Spearman P, Anderson E, Graham I, Noah DL, Mangal B, Kim S, Hill H, Whitaker J, Emery W, Beck A, Stephens K, Hartwell B, Ogilvie M, Rimann N, Osinski E, Destefano E, Gajadhar T, Strudwick A, Pierce K, Lai L, Yue L, Wang D, Ying C, Cline A, Foltz T, Wagner N, Dull G, Pacatte T, Taggart B, Johnson V, Haller L, Looney C, Li S, May M, Myers B, May R, Parker L, Cochran N, Bowen D, Bell M, Scoggins J, Burns A, Stablein C, Wolff M, Jolles B, Leung B, Lambert L, Shorer S, Buchanan W, Murray S, Chang S, Gorman R. Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open Forum Infect Dis. 2014 Nov 18;1(3):ofu102. doi: 10.1093/ofid/ofu102. eCollection 2014 Dec. PMID: 25734170; PMCID: PMC4324215.
Copy Download .nbib Format: NLM
A new strategy for label-free detection of lymphoma cancer cells.

Biomedical optics express

Martucci NM, Rea I, Ruggiero I, Terracciano M, De Stefano L, Migliaccio N, Palmieri C, Scala G, Arcari P, Rendina I, Lamberti A.
PMID: 25909019
Biomed Opt Express. 2015 Mar 19;6(4):1353-62. doi: 10.1364/BOE.6.001353. eCollection 2015 Apr 01.

In this paper, a new strategy for highly selective and sensitive direct detection of lymphoma cells by exploiting the interaction between a peptide and its B-cell receptor, has been evaluated. In particular, an idiotype peptide, able to specifically bind...

Cite
Martucci NM, Rea I, Ruggiero I, et al. A new strategy for label-free detection of lymphoma cancer cells. Biomed Opt Express. 2015;6(4):1353-62doi: 10.1364/BOE.6.001353.
Martucci, N. M., Rea, I., Ruggiero, I., Terracciano, M., De Stefano, L., Migliaccio, N., Palmieri, C., Scala, G., Arcari, P., Rendina, I., & Lamberti, A. (2015). A new strategy for label-free detection of lymphoma cancer cells. Biomedical optics express, 6(4), 1353-62. https://doi.org/10.1364/BOE.6.001353
Martucci, Nicola M, et al. "A new strategy for label-free detection of lymphoma cancer cells." Biomedical optics express vol. 6,4 (2015): 1353-62. doi: https://doi.org/10.1364/BOE.6.001353
Martucci NM, Rea I, Ruggiero I, Terracciano M, De Stefano L, Migliaccio N, Palmieri C, Scala G, Arcari P, Rendina I, Lamberti A. A new strategy for label-free detection of lymphoma cancer cells. Biomed Opt Express. 2015 Mar 19;6(4):1353-62. doi: 10.1364/BOE.6.001353. eCollection 2015 Apr 01. PMID: 25909019; PMCID: PMC4399674.
Copy Download .nbib Format: NLM
Activation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics.

Frontiers in behavioral neuroscience

Speranza L, Giuliano T, Volpicelli F, De Stefano ME, Lombardi L, Chambery A, Lacivita E, Leopoldo M, Bellenchi GC, di Porzio U, Crispino M, Perrone-Capano C.
PMID: 25814944
Front Behav Neurosci. 2015 Mar 11;9:62. doi: 10.3389/fnbeh.2015.00062. eCollection 2015.

Recent studies have indicated that the serotonin receptor subtype 7 (5-HT7R) plays a crucial role in shaping neuronal morphology during embryonic and early postnatal life. Here we show that pharmacological stimulation of 5-HT7R using a highly selective agonist, LP-211,...

Cite
Speranza L, Giuliano T, Volpicelli F, et al. Activation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics. Front Behav Neurosci. 2015;9:62doi: 10.3389/fnbeh.2015.00062.
Speranza, L., Giuliano, T., Volpicelli, F., De Stefano, M. E., Lombardi, L., Chambery, A., Lacivita, E., Leopoldo, M., Bellenchi, G. C., di Porzio, U., Crispino, M., & Perrone-Capano, C. (2015). Activation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics. Frontiers in behavioral neuroscience, 962. https://doi.org/10.3389/fnbeh.2015.00062
Speranza, Luisa, et al. "Activation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics." Frontiers in behavioral neuroscience vol. 9 (2015): 62. doi: https://doi.org/10.3389/fnbeh.2015.00062
Speranza L, Giuliano T, Volpicelli F, De Stefano ME, Lombardi L, Chambery A, Lacivita E, Leopoldo M, Bellenchi GC, di Porzio U, Crispino M, Perrone-Capano C. Activation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics. Front Behav Neurosci. 2015 Mar 11;9:62. doi: 10.3389/fnbeh.2015.00062. eCollection 2015. PMID: 25814944; PMCID: PMC4356071.
Copy Download .nbib Format: NLM
Modified denatured lysozyme effectively solubilizes fullerene c60 nanoparticles in water.

Nanotechnology

Siepi M, Politi J, Dardano P, Amoresano A, De Stefano L, Maria Monti D, Notomista E.
PMID: 28525394
Nanotechnology. 2017 Aug 18;28(33):335601. doi: 10.1088/1361-6528/aa744e. Epub 2017 May 19.

Fullerenes, allotropic forms of carbon, have very interesting pharmacological effects and engineering applications. However, a very low solubility both in organic solvents and water hinders their use. Fullerene C60, the most studied among fullerenes, can be dissolved in water...

Cite
Siepi M, Politi J, Dardano P, et al. Modified denatured lysozyme effectively solubilizes fullerene c60 nanoparticles in water. Nanotechnology. 2017;28(33):335601doi: 10.1088/1361-6528/aa744e.
Siepi, M., Politi, J., Dardano, P., Amoresano, A., De Stefano, L., Maria Monti, D., & Notomista, E. (2017). Modified denatured lysozyme effectively solubilizes fullerene c60 nanoparticles in water. Nanotechnology, 28(33), 335601. https://doi.org/10.1088/1361-6528/aa744e
Siepi, Marialuisa, et al. "Modified denatured lysozyme effectively solubilizes fullerene c60 nanoparticles in water." Nanotechnology vol. 28,33 (2017): 335601. doi: https://doi.org/10.1088/1361-6528/aa744e
Siepi M, Politi J, Dardano P, Amoresano A, De Stefano L, Maria Monti D, Notomista E. Modified denatured lysozyme effectively solubilizes fullerene c60 nanoparticles in water. Nanotechnology. 2017 Aug 18;28(33):335601. doi: 10.1088/1361-6528/aa744e. Epub 2017 May 19. PMID: 28525394.
Copy Download .nbib Format: NLM
Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party.

Blood transfusion = Trasfusione del sangue

Tagariello G, Castaman G, Falanga A, Santoro R, Napolitano M, Storti S, Veneri D, Basso M, Candiotto L, Tassinari C, Federici AB, De Stefano V.
PMID: 27416570
Blood Transfus. 2016 Nov;14(6):521-526. doi: 10.2450/2016.0321-15. Epub 2016 Jun 24.

BACKGROUND: Following high-dose chemotherapy/bone marrow transplantation, patients are routinely, prophylactically transfused with platelet concentrates (PC) if they have a platelet count ≤10×10MATERIALS AND METHODS: The GIMEMA Haemostasis and Thrombosis Working Party sent a questionnaire to Italian haematology departments to...

Cite
Tagariello G, Castaman G, Falanga A, et al. Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party. Blood Transfus. 2016;14(6):521-526doi: 10.2450/2016.0321-15.
Tagariello, G., Castaman, G., Falanga, A., Santoro, R., Napolitano, M., Storti, S., Veneri, D., Basso, M., Candiotto, L., Tassinari, C., Federici, A. B., De Stefano, V. (2016). Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party. Blood transfusion = Trasfusione del sangue, 14(6), 521-526. https://doi.org/10.2450/2016.0321-15
Tagariello, Giuseppe, et al. "Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party." Blood transfusion = Trasfusione del sangue vol. 14,6 (2016): 521-526. doi: https://doi.org/10.2450/2016.0321-15
Tagariello G, Castaman G, Falanga A, Santoro R, Napolitano M, Storti S, Veneri D, Basso M, Candiotto L, Tassinari C, Federici AB, De Stefano V. Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party. Blood Transfus. 2016 Nov;14(6):521-526. doi: 10.2450/2016.0321-15. Epub 2016 Jun 24. PMID: 27416570; PMCID: PMC5111376.
Copy Download .nbib Format: NLM
Usefulness of MRI in takotsubo cardiomyopathy: a review of the literature.

Cardiovascular diagnosis and therapy

Kohan AA, Levy Yeyati E, De Stefano L, Dragonetti L, Pietrani M, Perez de Arenaza D, Belziti C, García-Mónaco RD.
PMID: 24834411
Cardiovasc Diagn Ther. 2014 Apr;4(2):138-46. doi: 10.3978/j.issn.2223-3652.2013.10.03.

Takotsubo cardiomyopathy (TC) is a disease that can be misinterpreted as a more serious acute coronary syndrome. Its clinical characteristics resemble those of a myocardial infarct, while its imaging characteristics are critical on correctly characterizing and diagnosing the disease....

Cite
Kohan AA, Levy Yeyati E, De Stefano L, et al. Usefulness of MRI in takotsubo cardiomyopathy: a review of the literature. Cardiovasc Diagn Ther. 2014;4(2):138-46doi: 10.3978/j.issn.2223-3652.2013.10.03.
Kohan, A. A., Levy Yeyati, E., De Stefano, L., Dragonetti, L., Pietrani, M., Perez de Arenaza, D., Belziti, C., & García-Mónaco, R. D. (2014). Usefulness of MRI in takotsubo cardiomyopathy: a review of the literature. Cardiovascular diagnosis and therapy, 4(2), 138-46. https://doi.org/10.3978/j.issn.2223-3652.2013.10.03
Kohan, Andres Alejandro, et al. "Usefulness of MRI in takotsubo cardiomyopathy: a review of the literature." Cardiovascular diagnosis and therapy vol. 4,2 (2014): 138-46. doi: https://doi.org/10.3978/j.issn.2223-3652.2013.10.03
Kohan AA, Levy Yeyati E, De Stefano L, Dragonetti L, Pietrani M, Perez de Arenaza D, Belziti C, García-Mónaco RD. Usefulness of MRI in takotsubo cardiomyopathy: a review of the literature. Cardiovasc Diagn Ther. 2014 Apr;4(2):138-46. doi: 10.3978/j.issn.2223-3652.2013.10.03. PMID: 24834411; PMCID: PMC3996242.
Copy Download .nbib Format: NLM
Speciation of phytate ion in aqueous solution. Alkali metal complex formation in different ionic media.

Analytical and bioanalytical chemistry

De Stefano C, Milea D, Pettignano A, Sammartano S.
PMID: 12856098
Anal Bioanal Chem. 2003 Aug;376(7):1030-40. doi: 10.1007/s00216-003-2056-1. Epub 2003 Jul 11.

The acid-base properties of phytic acid [ myo-inositol 1,2,3,4,5,6-hexakis(dihydrogen phosphate)] (H(12)Phy; Phy(12-)=phytate anion) were studied in aqueous solution by potentiometric measurements ([H+]-glass electrode) in lithium and potassium chloride aqueous media at different ionic strengths (0< I mol L(-1)< or...

Cite
De Stefano C, Milea D, Pettignano A, et al. Speciation of phytate ion in aqueous solution. Alkali metal complex formation in different ionic media. Anal Bioanal Chem. 2003;376(7):1030-40doi: 10.1007/s00216-003-2056-1.
De Stefano, C., Milea, D., Pettignano, A., & Sammartano, S. (2003). Speciation of phytate ion in aqueous solution. Alkali metal complex formation in different ionic media. Analytical and bioanalytical chemistry, 376(7), 1030-40. https://doi.org/10.1007/s00216-003-2056-1
De Stefano, Concetta, et al. "Speciation of phytate ion in aqueous solution. Alkali metal complex formation in different ionic media." Analytical and bioanalytical chemistry vol. 376,7 (2003): 1030-40. doi: https://doi.org/10.1007/s00216-003-2056-1
De Stefano C, Milea D, Pettignano A, Sammartano S. Speciation of phytate ion in aqueous solution. Alkali metal complex formation in different ionic media. Anal Bioanal Chem. 2003 Aug;376(7):1030-40. doi: 10.1007/s00216-003-2056-1. Epub 2003 Jul 11. PMID: 12856098.
Copy Download .nbib Format: NLM
Binding of acrylic and sulphonic polyanions by open-chain polyammonium cations.

Talanta

Crea F, De Robertis A, De Stefano C, Sammartano S, Gianguzza A, Piazzese D.
PMID: 18968218
Talanta. 2001 Mar 16;53(6):1241-8. doi: 10.1016/s0039-9140(00)00617-2.

The interactions between some acrylic and sulphonic polyanions and some protonated amines (diamines NH(2)-(CH(2))(x)-NH(2), x=2,...,10; linear tri-, tetra-, penta- and hexa-amines) were studied potentiometrically in aqueous solution, at 25 degrees C. For both types of polyanions AL(2)H(i) (L(-), monomer...

Cite
Crea F, De Robertis A, De Stefano C, et al. Binding of acrylic and sulphonic polyanions by open-chain polyammonium cations. Talanta. 2001;53(6):1241-8doi: 10.1016/s0039-9140(00)00617-2.
Crea, F., De Robertis, A., De Stefano, C., Sammartano, S., Gianguzza, A., & Piazzese, D. (2001). Binding of acrylic and sulphonic polyanions by open-chain polyammonium cations. Talanta, 53(6), 1241-8. https://doi.org/10.1016/s0039-9140(00)00617-2
Crea, F, et al. "Binding of acrylic and sulphonic polyanions by open-chain polyammonium cations." Talanta vol. 53,6 (2001): 1241-8. doi: https://doi.org/10.1016/s0039-9140(00)00617-2
Crea F, De Robertis A, De Stefano C, Sammartano S, Gianguzza A, Piazzese D. Binding of acrylic and sulphonic polyanions by open-chain polyammonium cations. Talanta. 2001 Mar 16;53(6):1241-8. doi: 10.1016/s0039-9140(00)00617-2. PMID: 18968218.
Copy Download .nbib Format: NLM
The determination of formation constants of weak complexes by potentiometric measurements: experimental procedures and calculation methods.

Talanta

De Robertis A, De Stefano C, Sammartano S, Rigano C.
PMID: 18964435
Talanta. 1987 Nov;34(11):933-8. doi: 10.1016/0039-9140(87)80132-7.

Experimental and calculation procedures for the study of weak complexes by the pH-measurement technique are described. An algorithm for the calculation of formation constants, together with a computer program in FORTRAN and BASIC versions, is reported. The problems of...

Cite
De Robertis A, De Stefano C, Sammartano S, et al. The determination of formation constants of weak complexes by potentiometric measurements: experimental procedures and calculation methods. Talanta. 1987;34(11):933-8doi: 10.1016/0039-9140(87)80132-7.
De Robertis, A., De Stefano, C., Sammartano, S., & Rigano, C. (1987). The determination of formation constants of weak complexes by potentiometric measurements: experimental procedures and calculation methods. Talanta, 34(11), 933-8. https://doi.org/10.1016/0039-9140(87)80132-7
De Robertis, A, et al. "The determination of formation constants of weak complexes by potentiometric measurements: experimental procedures and calculation methods." Talanta vol. 34,11 (1987): 933-8. doi: https://doi.org/10.1016/0039-9140(87)80132-7
De Robertis A, De Stefano C, Sammartano S, Rigano C. The determination of formation constants of weak complexes by potentiometric measurements: experimental procedures and calculation methods. Talanta. 1987 Nov;34(11):933-8. doi: 10.1016/0039-9140(87)80132-7. PMID: 18964435.
Copy Download .nbib Format: NLM
Binding of polyanions by biogenic amines. I. Formation and stability of protonated putrescine and cadaverine complexes with inorganic anions.

Talanta

De Robertis A, De Stefano C, Gianguzza A, Sammartano S.
PMID: 18967233
Talanta. 1998 Aug;46(5):1085-93. doi: 10.1016/s0039-9140(97)00388-3.

The formation and stability of proton diamine-inorganic anion [Cl(-), SO(4)(2-), HPO(4)(2-), P(2)O(7)(4-) and Fe(CN)(6)(4-)] complexes was studied potentiometrically [(H(+))-glass electrode] at 25 degrees C. Several general formula ALH(r) complexes are formed in these various systems. The stability of complexes...

Cite
De Robertis A, De Stefano C, Gianguzza A, et al. Binding of polyanions by biogenic amines. I. Formation and stability of protonated putrescine and cadaverine complexes with inorganic anions. Talanta. 1998;46(5):1085-93doi: 10.1016/s0039-9140(97)00388-3.
De Robertis, A., De Stefano, C., Gianguzza, A., & Sammartano, S. (1998). Binding of polyanions by biogenic amines. I. Formation and stability of protonated putrescine and cadaverine complexes with inorganic anions. Talanta, 46(5), 1085-93. https://doi.org/10.1016/s0039-9140(97)00388-3
De Robertis, A, et al. "Binding of polyanions by biogenic amines. I. Formation and stability of protonated putrescine and cadaverine complexes with inorganic anions." Talanta vol. 46,5 (1998): 1085-93. doi: https://doi.org/10.1016/s0039-9140(97)00388-3
De Robertis A, De Stefano C, Gianguzza A, Sammartano S. Binding of polyanions by biogenic amines. I. Formation and stability of protonated putrescine and cadaverine complexes with inorganic anions. Talanta. 1998 Aug;46(5):1085-93. doi: 10.1016/s0039-9140(97)00388-3. PMID: 18967233.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 389 entries